From Patient Partnership to Pharma Impact
In today’s healthcare landscape, pharma is racing to develop life-changing therapies, but clinical trial innovation is being held back by a deeper issue: eroding patient trust.

As an industry, we need to rethink how we engage with communities, design trials that reflect the lived realities of diverse populations, and communicate outcomes in ways that build trust, foster transparency, and empower patients as true partners in research.
Download this new whitepaper that brings together practical insights from pharma executives, patient advocates, and strategists >>>  
Commentary and analysis by leading pharma experts:
  • Amy Akers Teets. Global Head Patient Strategy, Specialty Care, Sanofi
  • Tom Croce, VP, Patient Advocacy, Jazz Pharmaceuticals
  • Katie Sugarman, SVP, Clinical Development Strategy, Genmab
  • Daniel McNamara, Head of Patient Services, North America, Kyowa Kirin
  • Nirmit Kumar, Senior Global Medical Affairs Leader, Breast Cancer Dx, AstraZeneca
Don't get left behind. Read our latest expert analysis to elevate your clinical trial strategy >>>  
We hope you enjoy!

Kindest regards,
Download your white paper here

With analysis and case studies from senior leaders at AstraZeneca, Sanofi and Genmab.
I consent to Thomson Reuters using the personal information provided above to send me marketing communications about its products and services. I understand I can opt-out at any time.
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.